Skip to content

AcrySof™ IQ Vivity™ DFT315 (REF DFT315.200)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

Adverse event reports
8
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00380652421645), received between Aug 8, 2022 and Dec 12, 2025 — classified as 5 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Device Contamination with Chemical or Other Material1
  • Device Dislodged or Dislocated1
  • Particulates1
  • Scratched Material1

Patient problems

  • Insufficient Information3
  • Visual Impairment2
  • Blurred Vision1
  • Halo1
  • No Clinical Signs, Symptoms or Conditions1
  • Visual Disturbances1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 12, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A HEALTHCARE PROFESSIONAL REPORTED THAT, AFTER INTRAOCULAR LENS IMPLANTATION SURGERY, THE PATIENT REPORTED OF LENS POWER CHANGE. THE LENS WERE EXPLANTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 23788625 ↗
  • InjurySep 19, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated

    A HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, AFTER TWO WEEKS LENS WAS DISLOCATED. THE IOL WAS EXCHANGED FOR UNSPECIFIED LENS. THERE WAS NO FURTHER IMPACT TO THE PATIENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 23092733 ↗
  • InjuryMar 26, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRA-OCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED GLARE, HALOS AND POOR DEPTH PERCEPTION.THE IOL WAS EXCHANGED FOR ANOTHER LENS MODEL FOLLOWING THE INITIAL IMPLANT PROCEDURE. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Halo; Visual Disturbances

    MAUDE report 18977103 ↗
  • MalfunctionSep 15, 2023Particulates; Particulates

    ADDITIONAL INFORMATION WAS RECEIVED STATING THAT, THE LENS REMAINS IMPLANTED IN THE PATIENT'S EYE AND THERE IS NO ISSUES RELATED TO VISION OR OTHER CONDITIONS.

    Patient problems: Insufficient Information

    MAUDE report 17753865 ↗
  • InjuryJul 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED POOR VISION. THE LENS WAS EXPLANTED IN A SECONDARY PROCEDURE. THE CLINICAL REASON FOR THE EXPLANT WAS MULTIFOCAL INTOLERANCE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 17296596 ↗
  • MalfunctionApr 28, 2023Scratched Material; Scratched Material

    A HEALTHCARE PROFESSIONAL REPORTED THAT DURING CATARACT SURGERY WITH AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE IOL HAS SCRATCHES AND IT WAS REMAINED IN THE EYE. ADDITIONAL INFORMATION WAS RECEIVED STATING THE LENS WAS EXPLANTED AND REPLACED WITH ANOTHER LENS DURING INITIAL PROCEDURE. THERE WAS NO PATIENT HARM REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16829068 ↗
  • MalfunctionOct 14, 2022Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    AN OPHTHALMIC NURSE REPORTED THAT DURING A CATARACT EXTRACTION WITH AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, SURGEON NOTED A WHITE FILAMENT IN PARACENTESIS AND IT WAS REMOVED WITH FORCEPS AND THE SURGERY WAS COMPLETED. NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Insufficient Information

    MAUDE report 15603189 ↗
  • InjuryAug 8, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PURCHASING OFFICER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY VISION. THE INTRAOCULAR LENS WAS EXCHANGED WITH A MONOFOCAL LENS IN SECONDARY PROCEDURE IN A MONTH. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Blurred Vision

    MAUDE report 15183035 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.